Brendel Financial Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,192
Closed -$1.94M 101
2024
Q3
$1.94M Buy
2,192
+122
+6% +$110K 1.1% 42
2024
Q2
$1.87M Buy
+2,070
New +$1.66M 1.19% 39
2021
Q3
Sell
-275
Closed -$63K 182
2021
Q2
$63K Buy
+275
New +$55.2K 0.03% 153
2019
Q4
Sell
-1,950
Closed -$218K 86
2019
Q3
$218K Hold
1,950
0.2% 76
2019
Q2
$216K Buy
+1,950
New +$230K 0.21% 70
2019
Q1
Sell
-2,100
Closed -$243K 83
2018
Q4
$243K Buy
+2,100
New +$235K 0.28% 70

Other funds holding LLY

Brendel Financial Advisors's LLY Position: Q4 2024 in Review

Brendel Financial Advisors sold out of Eli Lilly (LLY) in Q4 2024, closing a stake of 2,192 shares — an estimated $1.94M sold.

Brendel Financial Advisors first reported a position in LLY in Q4 2018 and held it in 6 quarters. The position peaked at $1.94M in Q3 2024. 3,907 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

  • Brendel Financial Advisors reported no remaining Eli Lilly position as of Q4 2024 after selling out during the quarter.
  • Brendel Financial Advisors sold 2,192 Eli Lilly shares in Q4 2024, an estimated $1.94M.
  • Brendel Financial Advisors first reported a position in Eli Lilly in Q4 2018 and held it in 6 quarters.
  • Brendel Financial Advisors's Eli Lilly position peaked at $1.94M in Q3 2024.
  • 3,907 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on Brendel Financial Advisors's 13F filing for Q4 2024, filed 14 Jan 2025.